Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)
China · Delayed Price · Currency is CNY 13.98
+0.90 (6.88%)
Sep 30, 2026, 3:04 PM CST
SHE:300122 Market Cap
SHE:300122 has a market cap or net worth of 33.47 billion as of October 2, 2026. Its market cap has decreased by -32.69% in one year.
Market Cap
33.47B
Enterprise Value
41.80B
Revenue
8.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
13.98
ChartMarket Cap Chart
Since September 28, 2010, SHE:300122's market cap has increased from 15.42B to 33.47B, an increase of 117.02%. That is a compound annual growth rate of 4.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 33.47B | -25.91% |
| Dec 31, 2025 | 45.17B | -28.25% |
| Dec 31, 2024 | 62.96B | -57.07% |
| Dec 29, 2023 | 146.66B | 4.37% |
| Dec 30, 2022 | 140.53B | -29.51% |
| Dec 31, 2021 | 199.36B | -15.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai Allist Pharmaceuticals | 50.21B |
| Sunshine Guojian Pharmaceutical (Shanghai) | 37.13B |
| Shanghai RAAS Blood Products | 35.07B |
| Beijing Wantai Biological Pharmacy Enterprise | 34.57B |
| Suzhou Zelgen Biopharmaceuticals | 29.12B |
| Beijing Tiantan Biological Products | 24.90B |
| Hualan Biological Engineering | 24.35B |
| Acrobiosystems | 23.58B |